Clinical Trial

A Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy Participants

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The study has 2 groups, one each focusing on co-administration of elecoglipron and atorvastatin or rosuvastatin to assess the pharmacokinetics (PK) of atorvastatin in healthy participants.
Protocol Amendment History 3 changes
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-06-25
notable Enrollment increased: 40 -> 48 participants 2026-06-25
critical Recruitment opened 2026-05-13
Trial Details
NCT Number NCT07534592
Lead Sponsor AstraZeneca
Collaborators: Parexel
Conditions Healthy Participants
Enrollment 48 participants
Start Date 2026-04-16
Primary Completion 2026-08-28 (estimated)
Study Completion 2026-08-28 (estimated)
Updated on ClinicalTrials.gov 2026-06-24